| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/22/2010 | US20100183590 LSA-5 liver stage and blood stage antigen of Plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 07/22/2010 | US20100183589 Human blood proteins expressed in monocot seeds |
| 07/22/2010 | US20100183588 Mutated Netrin-4, Fragments Thereof And Their Use As Medicines |
| 07/22/2010 | US20100183587 Therapeutic Compositions for Treatment of Corneal Disorders |
| 07/22/2010 | US20100183586 Method for detection or treatment of graft versus host disease |
| 07/22/2010 | US20100183585 Methods and compositions for treating tumors and metastases through the modulation of latexin |
| 07/22/2010 | US20100183584 Conformation and activity of gbeta5 complexes |
| 07/22/2010 | US20100183583 Galk1s as modifiers of the pten/akt pathway and methods of use |
| 07/22/2010 | US20100183554 Anti-CD3 Antibodies and Methods of Use Thereof |
| 07/22/2010 | US20100183550 Benzothienopyridines For Use As Inhibitors Of EG5 Kinesin |
| 07/22/2010 | US20100183549 Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | US20100183547 Unmarked Recombinant Intracellular Pathogen Immunogenic Compositions Expressing High Levels of Recombinant Proteins |
| 07/22/2010 | US20100183546 Method for Increasing CD8+ Cytotoxic T Cell Responses and for Treating Multiple Sclerosis |
| 07/22/2010 | US20100183544 Method of treatment |
| 07/22/2010 | US20100183541 Methods of Treating Autoimmune Diseases |
| 07/22/2010 | US20100183518 Vaccine Against Group A Beta Hemolytic Streptococcus And Respective Process For Obtaining Thereof |
| 07/22/2010 | US20100183507 Tumor markers in ovarian cancer |
| 07/22/2010 | US20100183506 Antigen associated with lung cancers and lymphomas |
| 07/22/2010 | US20100183502 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials |
| 07/22/2010 | CA2749862A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 07/22/2010 | CA2749821A1 Ets-2 biomarkers for fibrotic diseases and uses thereof |
| 07/22/2010 | CA2749627A1 Recombinant monovalent antibodies |
| 07/22/2010 | CA2749572A1 Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins |
| 07/22/2010 | CA2749262A1 Purified plasmodium and vaccine compositions |
| 07/22/2010 | CA2749151A1 Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody |
| 07/22/2010 | CA2744294A1 Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation |
| 07/21/2010 | EP2208787A1 A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 07/21/2010 | EP2208784A1 Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 07/21/2010 | EP2208737A1 Complement factor H-derived short consensus repeat-antibody constructs |
| 07/21/2010 | EP2208736A2 Endogenous retrovirus up-regulated in prostate cancer |
| 07/21/2010 | EP2207875A1 Antigen-specific t-cell preparations from bone marrow |
| 07/21/2010 | EP2207809A1 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| 07/21/2010 | EP2207808A1 Improved nogo-a binding molecules and pharmaceutical use thereof |
| 07/21/2010 | EP2207807A2 Molecules and methods for modulating complement component |
| 07/21/2010 | EP2207804A1 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 07/21/2010 | EP2207803A1 Cd9-specific human antibodies |
| 07/21/2010 | EP2207797A1 Modulation of sirpalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 07/21/2010 | EP2207597A2 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment |
| 07/21/2010 | EP2207568A2 Antibodies specific for the protofibril form of beta-amyloid protein |
| 07/21/2010 | EP2207565A2 Immunotherapy regimes dependent on apoe status |
| 07/21/2010 | EP2207564A1 Use of mva to treat prostate cancer |
| 07/21/2010 | EP2207563A1 Preventive and therapeutic vaccine for stroke and neurological disorders |
| 07/21/2010 | EP1790332B1 Human papilloma virus vaccine for oral administration |
| 07/21/2010 | EP1684805B1 Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma |
| 07/21/2010 | EP1682177B1 Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 07/21/2010 | EP1667712B1 B. pertussis antigens and use thereof in vaccination |
| 07/21/2010 | EP1412502B1 Use of clya hemolysin for excretion of fusion proteins |
| 07/21/2010 | EP1276896B1 Epitope synchronization in antigen presenting cells |
| 07/21/2010 | EP1265928B1 Ultra high affinity rsv neutralizing antibodies |
| 07/21/2010 | EP1161537B2 Non-spreading pestivirus |
| 07/21/2010 | EP0724642B2 Nucleotide vector, composition containing such vector and vaccine for immunization against hepatitis |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN1685039B Secreted acid phosphatase (SAPM) is present only in pathogenic mycobacteria and expressed selectively at phagosomal PH |
| 07/21/2010 | CN101784566A Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 07/21/2010 | CN101784302A A modulator of nrg1 for treatment of respiratory disorders |
| 07/21/2010 | CN101784284A Set of means for treating a malignant pathology, an autoimmune disease or an infectious disease |
| 07/21/2010 | CN101784283A Low-additive influenza vaccines |
| 07/21/2010 | CN101784282A vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 07/21/2010 | CN101781632A Brucella melilitensis bp26 gene-deleted M5-90 vaccine strain |
| 07/21/2010 | CN101781368A Anti-amyloid beta antibodies and their use |
| 07/21/2010 | CN101781360A Recombinant rubella virus protein and application |
| 07/21/2010 | CN101780278A Bivalent hand-foot-and-mouth disease inactivated vaccine |
| 07/21/2010 | CN101780277A Immunogen composition containing polypeptide derived from cytomegalovirus and use method thereof |
| 07/21/2010 | CN101780276A Method for removing residual DNA in hydrophobia vaccine product by utilizing ultrasound combined with EDTA solution |
| 07/21/2010 | CN101780275A Development of H5N1 subtype avian influenza cold-adaption attenuated live vaccines and application thereof |
| 07/21/2010 | CN101780274A Inactivated vaccine for swine streptococcicosis and pasteurella multocida and preparation method thereof |
| 07/21/2010 | CN101780273A Vibrio harveyi secretory type vaccine and structure and application thereof |
| 07/21/2010 | CN101780272A Application of autovaccine preparation containing TGF beta 1 |
| 07/21/2010 | CN101780080A Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 07/21/2010 | CN101461942B Dendritic cell vaccine carrying recombinant human HSP70 polypeptide complexes, preparation method and application |
| 07/21/2010 | CN101234199B Hepatitis B and encephalitis B combined vaccine and preparation thereof |
| 07/21/2010 | CN101177451B Micrococcus pyogenes adhesion functional peptide and coded sequence thereof |
| 07/21/2010 | CN101100680B Recombination baculoviral for highly effectively expressing SARS coronavirus S protein and construction thereof |
| 07/20/2010 | US7759477 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics |
| 07/20/2010 | US7759476 Double-stranded RNAS directed to IKK-2 |
| 07/20/2010 | US7759474 used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 125P5C8 can be used in active or passive immunization |
| 07/20/2010 | US7759472 Administering platelet derived growth factor antagonist and endothelial growth factor antagonist |
| 07/20/2010 | US7759465 selectively inhibit induction of cytokines by human peripheral blood mononuclear cells (PBMCs) stimulated with ara-lipoarabinomannan (araLAM); for inflammation |
| 07/20/2010 | US7759464 N-glycosylated antibody |
| 07/20/2010 | US7759462 detecting Tir polypeptide of escherichia by contacting a sample with an anti-Tir (translocated intimin receptor) antibody immunospecific to the Tir polypeptide and detecting immunospecific binding of the anti-Tir antibody to the Tir polypeptide;kits |
| 07/20/2010 | US7759367 Pharmaceutical compositions and their uses |
| 07/20/2010 | US7759116 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced |
| 07/20/2010 | US7759106 Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli |
| 07/20/2010 | US7759104 Nutrient broth comprising measles virus; viral targeting of anticancer agents |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7759081 Diagnosing cancer in humans; obtain sample, detect annexin protein in sample, amplified concentration of annexins indicates cancer |
| 07/20/2010 | US7759075 Molecules for the treatment of lung disease involving an immune reaction to connective tissue found in the lung |
| 07/20/2010 | US7759071 Using nucleosome concentration after exposure to antitumor and/or anti-ischemic agents as diagnostic indicator of treatment efficacy |
| 07/20/2010 | US7759070 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 07/20/2010 | US7758893 Enteral compositions for the prevention and/or treatment of sepsis |
| 07/20/2010 | US7758876 Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides |
| 07/20/2010 | US7758875 Vaccine |
| 07/20/2010 | US7758874 Genetic engineered polypeptides; bactericide |
| 07/20/2010 | US7758873 Polysaccharide containing botulinum toxin pharmaceutical compositions and uses thereof |
| 07/20/2010 | US7758872 Method of treating depression |
| 07/20/2010 | US7758871 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin |
| 07/20/2010 | US7758870 Virulent isolate of Lawsonia intracellularis; protecting against and diagnosing porcine proliferative enteropathy |
| 07/20/2010 | US7758869 Immunization of animal; mixture with solid phase lipid; oral administering |
| 07/20/2010 | US7758868 genes having a modification that results in replacement of a lysine residue to a leucine, histidine or arginine residue, causing the transferase enzymes to have increased fidelity compared to an enzyme encoded by a wild-type gene not having the modification; vaccines |